🇺🇸 FDA
Pipeline program

tiotropium 18 mcg

205.368

Approved small_molecule completed

Quick answer

tiotropium 18 mcg for Pulmonary Disease, Chronic Obstructive is a Approved program (small_molecule) at Boehringer Ingelheim with 1 ClinicalTrials.gov record(s).

Program details

Company
Boehringer Ingelheim
Indication
Pulmonary Disease, Chronic Obstructive
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials